Patent · US Active

Synthesis and crystalline forms of NPY5 antagonist

US7700611B2 · kind B2 · utility

0Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 24, 2006
Grant dateApr 20, 2010
Priority date
Expiry dateSep 26, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to a process for producing crystalline trans-N-[1-(2-fluorophenyl)-S-pyrazoly]-3-ox-ospiro[6-azaisobenzofuran-1(3H),1′-cyclohexane]-4′-carboxamide and novel salts, hydrates and polymorphs thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.